Tempus Ai, Inc.
A maker of AI-driven precision medicine tools, Tempus runs a platform that analyzes tumor samples and other health data to help doctors personalize cancer, hereditary, and neuropsychiatry care. Its Diagnostics line performs genomic tests, while Data & Applications sells anonymized health insights and trial-matching services to drugmakers. Founded in 2015 by Eric Lefkofsky, it takes its name from the Latin for "time" — a nod to giving patients more of it.
Granted 263.4K · Sold 2.30M
Granted 85.0K · Sold 77.5K
Granted 5.9K
Granted 48.4K · Sold 52.3K
Granted 5.9K
Granted 47.5K · Sold 71.1K
Granted 13.6K · Sold 4.3K
Sold 14.3K
Granted 37.0K · Sold 8.9K
Granted 5.9K
Granted 5.9K
Granted 5.9K
Granted 5.9K · Sold 1.7K
Granted 5.9K · Sold 3.7K
Granted 5.9K · Sold 6.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Lefkofsky Eric PCEO and Chairman, Director, 10% owner · 107 transactions | — | 46.86M | 263.4K | — | 2.30M |
| Fukushima RyanCEO, Data · 28 transactions | -45.4% | 609.9K | 85.0K | — | 77.5K |
| Leonsis TheodoreDirector · 1 transaction | +4.5% | 137.8K | 5.9K | — | — |
| Polovin AndrewEVP, Chief Legal Officer · 13 transactions | -2.9% | 128.2K | 48.4K | — | 52.3K |
| Barris Peter JDirector · 1 transaction | +5.1% | 121.4K | 5.9K | — | — |
| Rogers James WilliamChief Financial Officer · 11 transactions | -17% | 114.9K | 47.5K | — | 71.1K |
| Schoenherr Thomas EdwardCEO, Diagnostics · 3 transactions | — | 87.0K | 13.6K | — | 4.3K |
| Phelps ErikEVP, Chief Admin. Officer · 5 transactions | -9.2% | 85.5K | — | — | 14.3K |
| Bartolucci Ryan MChief Accounting Officer · 6 transactions | +61.2% | 74.0K | 37.0K | — | 8.9K |
| Gottlieb ScottDirector · 1 transaction | +17% | 40.7K | 5.9K | — | — |
| West NadjaDirector · 1 transaction | +18.4% | 38.0K | 5.9K | — | — |
| Belcher Eric DDirector · 1 transaction | +20% | 35.5K | 5.9K | — | — |
| Epstein David RDirector · 7 transactions | +15.3% | 31.5K | 5.9K | — | 1.7K |
| Frederick Wayne A.I.Director · 2 transactions | +7.8% | 30.7K | 5.9K | — | 3.7K |
| Doudna Jennifer ADirector · 5 transactions | -2.3% | 25.9K | 5.9K | — | 6.5K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -2.54M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.